share_log

HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

HC Wainwright & Co.维持对Mind Medicine的买入,将目标股价下调至35美元
Benzinga ·  05/10 15:39

HC Wainwright & Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:MNMD) with a Buy and lowers the price target from $75 to $35.

HC Wainwright & Co. 分析师帕特里克·特鲁基奥维持Mind Medicine(纳斯达克股票代码:MNMD)的买入并将目标股价从75美元下调至35美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发